Oncology House Physician Model: a Response to Changes in Pediatric Resident Coverage
Overview
Authors
Affiliations
Background: Given decreasing resident duty hours, subspecialty hospitalist models have emerged to help compensate for the restructured presence of residents. We sought to examine the impact of our pediatric oncology hospitalist model on the oncology unit staff.
Procedure: The survey was developed after a literature review of subspecialty hospitalist models. The final surveys were designed using a 5-point Likert scale. Descriptive statistics were used to compile baseline demographic characteristics of respondents and overall responses to survey questions.
Results: Respondents agreed that house physicians provide better continuity of care (96.8%), are more comfortable with the experience level of the physician (98.4%), and are better able to answer questions (92%). Respondents also agreed that house physicians serve as backup for system-related and patient-related questions and found security knowing an experienced provider was on the floor (87.5%). Responses to open-ended questions indicated that the house physician model has impacted fellow education.
Conclusions: Our oncology house physician model helps account for decreased residency duty hours. This can serve as a model for other institutions requiring subspecialty inpatient coverage, given resident work hour restrictions. Adjustments in the clinical education of hematology/oncology fellows need to be considered in the setting of competent, consistent, and experienced front-line providers.
An H, Choi Y, Lee S, Kim M, Park H, Kim B Children (Basel). 2023; 10(8).
PMID: 37628399 PMC: 10453551. DOI: 10.3390/children10081400.
Clinicians' experience of providing care: a rapid review.
Iqbal M, Manias E, Mimmo L, Mears S, Jack B, Hay L BMC Health Serv Res. 2020; 20(1):952.
PMID: 33059673 PMC: 7559170. DOI: 10.1186/s12913-020-05812-3.
The Hospitalist Model and Oncology: Oncologist Opinions About Inpatient Cancer Care Delivery.
Atlas K, Egan B, Novak C, Sidlow R Oncologist. 2020; 25(12):e2006-e2009.
PMID: 32744351 PMC: 8108059. DOI: 10.1634/theoncologist.2020-0514.